Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-49362

Single-particle
2.58 Å
EMD-49362 Deposition: 21/02/2025
Map released: 08/10/2025
Last modified: 08/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-49362

Structure of the cross-HLA supertype antibody R302 bound to a class I MHC presenting a divarasib-modified KRAS-G12C peptide on HLA-A*03

EMD-49362

Single-particle
2.58 Å
EMD-49362 Deposition: 21/02/2025
Map released: 08/10/2025
Last modified: 08/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Binary complex of Fab R302 with divarasib-conjugated KRAS G12C peptide (7-16) presented by class I MHC having HLA-A*03:01
Fitted models: 9nfc

Deposition Authors: Maso L

Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy

Grant Support: